| 000 | 01689 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515153735.0 | ||
| 264 | 0 | _c20100920 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1533-4023 | ||
| 024 | 7 |
_a10.1097/FJC.0b013e318195bfbc _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFraser, Heather | |
| 245 | 0 | 0 |
_aVarespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _cJan 2009 |
||
| 300 |
_a60-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAcetates |
| 650 | 0 | 4 | _aAneurysm |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta _xpathology |
| 650 | 0 | 4 |
_aApolipoproteins E _xdeficiency |
| 650 | 0 | 4 |
_aArteriosclerosis _xenzymology |
| 650 | 0 | 4 |
_aAtherosclerosis _xenzymology |
| 650 | 0 | 4 | _aBlood Proteins |
| 650 | 0 | 4 | _aCholesterol |
| 650 | 0 | 4 | _aGroup II Phospholipases A2 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndoles |
| 650 | 0 | 4 | _aKeto Acids |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aPhospholipases A2, Secretory _xantagonists & inhibitors |
| 700 | 1 | _aHislop, Colin | |
| 700 | 1 | _aChristie, Robert M | |
| 700 | 1 | _aRick, Heather L | |
| 700 | 1 | _aReidy, Charles A | |
| 700 | 1 | _aChouinard, Michael L | |
| 700 | 1 | _aEacho, Patrick I | |
| 700 | 1 | _aGould, Kenneth E | |
| 700 | 1 | _aTrias, Joaquim | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 53 _gno. 1 _gp. 60-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FJC.0b013e318195bfbc _zAvailable from publisher's website |
| 999 |
_c18578846 _d18578846 |
||